Consistent with these results, enzyme-linked immunosorent assay (ELISA) confirmed that mid and endpoint measures of serum leptin were significantly lower in HU vs. AMB mice (Fig. 2g), whereas blood panels confirmed that all mice were healthy and free of metabolic disease throughout the study time course (Supplementary Fig. S1). The gene discussed is LEP; the disease is Other metabolic disease.